CCI
GHDX

Columbus Circle Investors’s Genomic Health, Inc. GHDX Stock Holding History

Columbus Circle Investors’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-31,607
Closed -$914K – 324
2016
Q3 		$914K Sell
31,607
-21,546
-41% -$600K 0.01% 255
2016
Q2 		$1.38M Buy
+53,153
New +$1.41M 0.01% 220

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Columbus Circle Investors's GHDX Position: Q4 2016 in Review

Columbus Circle Investors sold out of Genomic Health, Inc. (GHDX) in Q4 2016, closing a stake of 31,607 shares — an estimated $914K sold.

Columbus Circle Investors first reported a position in GHDX in Q2 2016 and held it in 2 quarters. The position peaked at $1.38M in Q2 2016. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

  • Columbus Circle Investors reported no remaining Genomic Health, Inc. position as of Q4 2016 after selling out during the quarter.
  • Columbus Circle Investors sold 31,607 Genomic Health, Inc. shares in Q4 2016, an estimated $914K.
  • Columbus Circle Investors first reported a position in Genomic Health, Inc. in Q2 2016 and held it in 2 quarters.
  • Columbus Circle Investors's Genomic Health, Inc. position peaked at $1.38M in Q2 2016.
  • 133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on Columbus Circle Investors's 13F filing for Q4 2016, filed 2 Feb 2017.